StonvexLoading…
StonvexStonvexStonvexCore line items from MAR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $26.19B | $25.10B | $23.71B | $20.77B |
Operating Income | $4.14B | $3.77B | $3.86B | $3.46B |
Net Income | $2.60B | $2.38B | $3.08B | $2.36B |
EPS (Diluted) | $9.51 | $8.33 | $10.18 | $7.24 |
Total Assets | $27.54B | $26.18B | $25.67B | $24.82B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $358.00M | $396.00M | $338.00M | $507.00M |
Free Cash Flow OCF − CapEx | $2.61B | $2.00B | $2.72B | $2.03B |
Shares Outstanding | 265.86M | 276.67M | 290.54M | 310.60M |